Joel B Epstein
Overview
Explore the profile of Joel B Epstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
296
Citations
5283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eichhorn S, Pili R, Epstein J, Rajesh R, Satheeshkumar P
Support Care Cancer
. 2025 Mar;
33(4):285.
PMID: 40088263
Background: The adverse outcomes and costs of immunotherapy (IT) have yet to be fully explored. Our study aims to assess the association between the use of IT in patients with...
2.
Epstein J, Parker I, Anand S
Support Care Cancer
. 2025 Mar;
33(4):256.
PMID: 40053137
No abstract available.
3.
Guneri P, Ilhan B, Bolukbasi G, Veral A, Epstein J
J Oral Pathol Med
. 2025 Mar;
PMID: 40043712
Background: The dynamic nature of oral epithelial dysplasia, involving both progression and regression over time, complicates prognostic predictions for the lesion. Objective: This paper addresses the intricacies of this challenge...
4.
Mohan M, Pili R, Epstein J, Rudin L, Eichhorn S, Satheeshkumar P
Support Care Cancer
. 2024 Dec;
33(1):22.
PMID: 39666090
Background: Our study aims to assess the association between chemotherapy-induced oral ulcerative mucositis (CT-UM) or radiotherapy-induced oral ulcerative mucositis (RT-UM) and the burden of illness (BOI), dysphagia, and disparities among...
5.
Guneri P, Bolukbasi G, Ilhan B, Epstein J, Warnakulasuriya S
Head Neck
. 2024 Nov;
47(1):7-13.
PMID: 39555829
Oral epithelial dysplasia (OED) is the primary histological marker for assessing the progression of oral potentially malignant disorders (OPMDs) to cancer. Despite challenges in grading and low inter-pathologist reproducibility, OED...
6.
Hong C, Jensen S, Vissink A, Bonomo P, Santos-Silva A, Gueiros L, et al.
Support Care Cancer
. 2024 Nov;
32(12):779.
PMID: 39520581
No abstract available.
7.
Dequae C, Raber-Durlacher J, Epstein J, de Vries R, Laheij A
Support Care Cancer
. 2024 Sep;
32(10):687.
PMID: 39320564
Purpose: This review aimed to evaluate the prevalence and characteristics of dysgeusia after hematopoietic cell transplantation (HCT). Methods: A literature search (in PubMed, Embase.com and Web of Science) for clinical...
8.
Prevalence of oral diseases in patients under palliative care: a systematic review and meta-analysis
Silva M, Santos E, Pedroso C, Epstein J, Santos-Silva A, Kowalski L
Support Care Cancer
. 2024 Aug;
32(9):607.
PMID: 39172259
Purpose: Oral alterations are frequently observed in patients undergoing palliative care and are linked to the direct or indirect effects of the primary medical condition, comorbidities and medical management, leading...
9.
Akbari E, Epstein J, Samim F
Curr Oncol Rep
. 2024 Aug;
26(11):1388-1397.
PMID: 39133417
Purpose Of Review: Fusobacterium nucleatum (F. nucleatum), an anaerobic, gram-negative microbe, commonly found in human dental biofilm and the gut flora. It has long been known to have a higher...
10.
Saldivia-Siracusa C, Santana Dos Santos E, Gonzalez-Arriagada W, Prado-Ribeiro A, Bianca Brandao T, Owosho A, et al.
Dent J (Basel)
. 2024 Jul;
12(7).
PMID: 39057001
Cancer disclosure represents a complex healthcare dynamic. Physicians or caregivers may be prompted to withhold diagnosis information from patients. This study aims to comprehensively map and synthesize available evidence about...